期刊文献+

麝香保心丸在冠心病心绞痛急性发作中的应用分析 被引量:8

Application Analysis of Shexiang Baoxin Pill on Acute Attack of Angina of Coronary Heart Disease
下载PDF
导出
摘要 目的:观察麝香保心丸在冠心病患者心绞痛急性发作治疗中的应用。方法:选取冠心病心绞痛急性发作患者72例,将其随机分为对照组和治疗组各36例。对照组采用常规西药治疗,治疗组在对照组治疗基础上加用麝香保心丸。观察比较两组患者的治疗效果。结果:治疗组总有效率为86.11%,明显高于对照组的61.11%(P<0.05)。结论:麝香保心丸在冠心病急性发作时可改善心肌缺血并快速缓解患者症状,值得临床推广应用。 Objective : To observe the Shexiang Baoxin Pill on angina pectoris of coronary heart disease in patients with acute episode of application in the treatment of. Methods: 72 cases of angina pectoris of coronary heart disease in patients with acute attack, which were divided into control group and treatment group with 36 cases in each. The control group was treated with conventional western medicine, the treatment group in the control group on the basis of Shexiang Baoxin pill. To observe the therapeutic effect of two groups were compared. Results:the total effective rate of treatment group was 86.11%, significantly higher than 61.11% in the control group (P〈0.05). Conclusion : Shexiang Baoxin Pill in the acute coronary heart disease can improve myocardial ischemia and alleviate symptoms, is worth the clinical to apply.
作者 周云
出处 《亚太传统医药》 2014年第11期117-118,共2页 Asia-Pacific Traditional Medicine
关键词 冠心痛 心绞痛 麝香保心丸 Coronary Heart Disease Angina Pectoris Shexiang Baoxin Pill
  • 相关文献

参考文献5

二级参考文献33

共引文献35

同被引文献107

  • 1申淑兰.中医药治疗冠心病心绞痛的作用机制[J].中草药,2005,36(4):634-636. 被引量:10
  • 2尤士杰,杨跃进,陈可冀,高润霖,吴永健,张健,荆志诚,白东峰,王燕武,陈纪林.通心络对急性心肌梗死患者再灌注后心肌和微血管的保护性研究[J].中华心血管病杂志,2005,33(5):433-437. 被引量:77
  • 3Jamkhande PG, Chandak PG, Dhawale SC, et al. Therapeutic ap- proaches to drug targets in atherosclerosis[ J]. Saudi pharmaceu- tical journal: SPJ: the official publication of the Saudi Pharma- ceutical Society,2014,22 ( 3 ) : 179 - 90.
  • 4Luo Y ,Jiang D ,Wen D ,et al. Changes in serum interleukin - 6 and high - sensitivity C - reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin [ J ]. Heart and vessels,2004,19(6) :257 -62.
  • 5Hung MJ , Cherug WJ , Cheng CW , et al. Comparison of serum levels of inflammatory markers in patients with coronary vaso- spasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syn- dromes with significant fixed coronary artery disease [ J ]. The A- merican journal of cardiology ,2006,97 ( 10 ) : 1429 - 34.
  • 6Rocchi E, Bursi F, Ventura P, et al. Anti - and pro - oxidant factors and endothelial dysfunction in chronic cigarette smokers with coronary heart disease [ J ]. European journal of internal medicine, 2007,18 (4) : 314 - 20.
  • 7Arroyo - Espliguero R, Avanzas P, Quiles J, et al. C - reactive protein predicts functional status and correlates with left ventric- ular ejection fraction in patients with chronic stable angina[ J ]. Atherosclerosis ,2009,205 ( 1 ) : 319 - 24.
  • 8Wang Y, Li L, Tan HW, et al. Transcoronary concentration gra- dient of sCIMOL and hsCRP in patients with coronary heart dis- ease[J]. Clinical cardiology 2007,30(2) :86 -91.
  • 9Jones RD, Nettleship JE, Kapoor D, et al. Testosterone and ath- erosclerosis in aging men: purported association and clinical im- plications [ J ]. American journal of cardiovascular drugs: drugs, devices, and other interventions,2005,5 (3) : 141 - 54.
  • 10Hung MJ,Cherng WJ,Cheng CW,et al.Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease[J].Am J Cardiol,2006;97(10):1429-34.

引证文献8

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部